Growth Metrics

Apyx Medical (APYX) Net Cash Flow Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -53.07%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.60%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -562.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -283.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -564.44%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 76.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -31.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -394.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 57.36%
10 Apyx Medical 174.53 Mn 143.65 Mn 7.93 Mn 25.00%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 25.00%
Dec 31, 2025 86.72%
Sep 30, 2025 12.79%
Jun 30, 2025 68.14%
Mar 31, 2025 88.53%
Dec 31, 2024 -83.39%
Sep 30, 2024 -224.74%
Jun 30, 2024 -300.56%
Mar 31, 2024 -204.25%
Dec 31, 2023 560.04%
Sep 30, 2023 167.99%
Jun 30, 2023 136.76%
Mar 31, 2023 230.26%
Dec 31, 2022 -2,882.17%
Sep 30, 2022 -42.36%
Jun 30, 2022 -28.56%
Mar 31, 2022 -103.86%
Dec 31, 2021 89.80%
Sep 30, 2021 -51.35%
Jun 30, 2021 5.88%
Mar 31, 2021 69.19%
Dec 31, 2020 55.79%
Sep 30, 2020 50.37%
Jun 30, 2020 -114.83%
Mar 31, 2020 -147.30%
Dec 31, 2019 85.54%
Sep 30, 2019 -115.78%
Jun 30, 2019 4,330.63%
Mar 31, 2019 1,310.33%
Dec 31, 2018 -5,134.94%
Sep 30, 2018 3,746.77%
Jun 30, 2018 32.07%
Mar 31, 2018 55.66%
Dec 31, 2017 -90.57%
Sep 30, 2017 -17,720.00%
Jun 30, 2017 -821.21%
Mar 31, 2017 -25.50%
Dec 31, 2016 462.71%
Sep 30, 2016 100.56%
Jun 30, 2016 89.92%
Mar 31, 2016 -124.31%
Dec 31, 2015 -247.51%
Sep 30, 2015 -258.04%
Jun 30, 2015 -14.93%
Mar 31, 2015 898.60%
Dec 31, 2014 -107.41%
Mar 31, 2014 -202.50%
Dec 31, 2013 1,763.50%
Mar 31, 2013 47.44%
Dec 31, 2012 38.26%
Sep 30, 2012 -61.76%
Jun 30, 2012 -31.43%
Mar 31, 2012 -221.37%